Literature DB >> 11326644

A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer.

M Lundin1, S Nordling, M Carpelan-Holmstrom, J Louhimo, H Alfthan, U H Stenman, C Haglund.   

Abstract

BACKGROUND: Production of the glycoprotein hormone hCG beta has been associated with aggressive behavior in nontrophoblastic tumors. In this study the prognostic value of serum level and tissue expression of hCG beta were compared in 232 patients with colorectal cancer.
MATERIALS AND METHODS: Serum levels were measured with a hCG beta specific immunofluorometric assay. Tissue specimens were stained with the same monoclonal antibody as in the serum assay.
RESULTS: The proportion of patients with a positive immunohistochemical expression of hCG beta was higher (22%) than the proportion with elevated serum levels (17%). The correlation between serum and tissue expression was moderate (kappa 0.298). Both serum and tissue expression of hCG beta were independent prognostic factors. hCG beta serum level was a stronger prognostic factor than tissue expression both in uni- and in multivariate analysis. The accuracy when predicting 5-year survival status of the patients was highest (63%) when using the combined results of serum and tissue expression.
CONCLUSIONS: There is a moderate correlation between hCG beta expression in serum and in tissue. The predictive accuracy of serum hCG beta was higher than the predictive accuracy of tissue expression, and the prognostic accuracy was further slightly increased when using a combination of tissue and serum expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11326644

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.

Authors:  Kristina Hotakainen; Susanna Lintula; Börje Ljungberg; Patrik Finne; Annukka Paju; Ulf-Håkan Stenman; Jakob Stenman
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

2.  Methodology and applications of disease biomarker identification in human serum.

Authors:  Ziad J Sahab; Suzan M Semaan; Qing-Xiang Amy Sang
Journal:  Biomark Insights       Date:  2007-02-14

3.  Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions.

Authors:  Sari Räty; Juhani Sand; Henrik Alfthan; Caj Haglund; Isto Nordback
Journal:  J Gastrointest Surg       Date:  2004 Jul-Aug       Impact factor: 3.452

Review 4.  Human Chorionic Gonadotropin and Breast Cancer.

Authors:  Susanne Schüler-Toprak; Oliver Treeck; Olaf Ortmann
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

5.  The transgenic expression of the β-subunit of human chorionic gonadotropin influences the growth of implanted tumor cells.

Authors:  Poonam Singh; Moumita Sarkar; Usha Agrawal; Ilpo Huhtaniemi; Rahul Pal
Journal:  Oncotarget       Date:  2018-10-05

6.  Transgenesis-mediated reproductive dysfunction and tumorigenesis: effects of immunological neutralization.

Authors:  Ruchi Sachdeva; Neetu Bhardwaj; Ilpo Huhtaniemi; Usha Aggrawal; Swatantra Kumar Jain; Rana Zaidi; Om Singh; Rahul Pal
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Synergistic activation of innate and adaptive immune mechanisms in the treatment of gonadotropin-sensitive tumors.

Authors:  Anjali Bose; Ilpo Huhtaniemi; Om Singh; Rahul Pal
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

8.  Human Chorionic Gonadotropin (hCG)-An Endocrine, Regulator of Gestation and Cancer.

Authors:  Helene Heidegger; Udo Jeschke
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.